| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 6.93e-05 | 2 | 156 | 2 | 1.20.1420.10 | |
| Domain | DUF3827 | 6.93e-05 | 2 | 156 | 2 | PF12877 | |
| Domain | VBS | 6.93e-05 | 2 | 156 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 6.93e-05 | 2 | 156 | 2 | IPR015009 | |
| Domain | Talin_cent | 6.93e-05 | 2 | 156 | 2 | IPR015224 | |
| Domain | DUF3827 | 6.93e-05 | 2 | 156 | 2 | IPR024606 | |
| Domain | Talin_middle | 6.93e-05 | 2 | 156 | 2 | PF09141 | |
| Domain | IRS | 1.94e-04 | 14 | 156 | 3 | PF02174 | |
| Domain | IRS_PTB | 1.94e-04 | 14 | 156 | 3 | IPR002404 | |
| Domain | TORC_N | 2.07e-04 | 3 | 156 | 2 | IPR024783 | |
| Domain | TORC | 2.07e-04 | 3 | 156 | 2 | IPR024786 | |
| Domain | TORC_M | 2.07e-04 | 3 | 156 | 2 | IPR024784 | |
| Domain | TORC_C | 2.07e-04 | 3 | 156 | 2 | IPR024785 | |
| Domain | TORC_N | 2.07e-04 | 3 | 156 | 2 | PF12884 | |
| Domain | TORC_M | 2.07e-04 | 3 | 156 | 2 | PF12885 | |
| Domain | TORC_C | 2.07e-04 | 3 | 156 | 2 | PF12886 | |
| Domain | Talin-1 | 2.07e-04 | 3 | 156 | 2 | IPR015710 | |
| Domain | ILWEQ_dom | 4.11e-04 | 4 | 156 | 2 | IPR002558 | |
| Domain | ILWEQ | 4.11e-04 | 4 | 156 | 2 | SM00307 | |
| Domain | FERM_f0 | 4.11e-04 | 4 | 156 | 2 | PF16511 | |
| Domain | ILWEQ | 4.11e-04 | 4 | 156 | 2 | PD011820 | |
| Domain | CLASP_N | 4.11e-04 | 4 | 156 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 4.11e-04 | 4 | 156 | 2 | IPR024395 | |
| Domain | DUF4195 | 4.11e-04 | 4 | 156 | 2 | IPR025243 | |
| Domain | - | 4.11e-04 | 4 | 156 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 4.11e-04 | 4 | 156 | 2 | PF01608 | |
| Domain | I_LWEQ | 4.11e-04 | 4 | 156 | 2 | PS50945 | |
| Domain | SPHK1-interactor_AKAP_110 | 4.11e-04 | 4 | 156 | 2 | IPR008382 | |
| Domain | FERM_f0 | 4.11e-04 | 4 | 156 | 2 | IPR032425 | |
| Domain | DUF4195 | 4.11e-04 | 4 | 156 | 2 | PF13836 | |
| Domain | AKAP_110 | 4.11e-04 | 4 | 156 | 2 | PF05716 | |
| Domain | FERM_CS | 1.02e-03 | 24 | 156 | 3 | IPR019747 | |
| Domain | Vinculin/catenin | 1.42e-03 | 7 | 156 | 2 | IPR006077 | |
| Domain | ZF_CCHHC | 1.42e-03 | 7 | 156 | 2 | PS51802 | |
| Domain | PIPKc | 1.88e-03 | 8 | 156 | 2 | SM00330 | |
| Domain | - | 1.88e-03 | 8 | 156 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 1.88e-03 | 8 | 156 | 2 | PF01504 | |
| Domain | PIPK | 1.88e-03 | 8 | 156 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 1.88e-03 | 8 | 156 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 1.88e-03 | 8 | 156 | 2 | IPR027483 | |
| Domain | - | 1.88e-03 | 8 | 156 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 1.88e-03 | 8 | 156 | 2 | IPR002498 | |
| Pubmed | SMG1 DMXL2 KDM3B SNRK TAB2 SPAG9 CHD7 GPR158 LMO7 PHF3 TLN1 NAV2 MACF1 TLN2 AKAP11 | 1.48e-13 | 225 | 158 | 15 | 12168954 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 CRTC3 CLASP1 KIF26B COBLL1 CKAP5 KDM3B TAB2 TBC1D22B IRS1 LUZP1 CDCA2 LMO7 PHF3 NAV2 MACF1 AKAP11 TNFAIP3 R3HDM1 CAMSAP2 CEP170B CRTC2 ZC3HAV1 | 9.68e-12 | 861 | 158 | 23 | 36931259 |
| Pubmed | MON2 RIPOR2 CLASP1 TRO CKAP5 BEND3 PIP5K1C PHF3 SPHKAP TLN1 MACF1 RAB11FIP4 R3HDM1 CAMSAP2 ST18 CEP170B | 6.69e-11 | 407 | 158 | 16 | 12693553 | |
| Pubmed | DLG5 ANK3 SYNM CKAP5 KIAA1549 TAB2 TBC1D22B FAM193A EIF4ENIF1 MACF1 R3HDM1 CNOT1 ZC3HAV1 | 2.75e-10 | 263 | 158 | 13 | 34702444 | |
| Pubmed | SMG1 DLG5 SDK2 RTN4 ZNF280C PHRF1 SANBR KDM3B KIAA1549 SNRK TIAM2 PLPPR4 LMO7 NAV2 AKAP11 L3MBTL3 CNOT1 | 3.69e-10 | 529 | 158 | 17 | 14621295 | |
| Pubmed | DMXL2 ANK3 CLASP1 TCOF1 UBR4 KSR2 CKAP5 NSD1 CHD7 LUZP1 SHANK2 PLPPR4 GPR158 SPHKAP MACF1 TLN2 PARN SPATS2 CAMSAP2 CNOT1 CEP170B RASAL1 | 5.44e-10 | 963 | 158 | 22 | 28671696 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | DLG5 TCOF1 SYNM KIF26B RTN4 CKAP5 LUZP1 CDCA2 EIF4ENIF1 LMO7 TLN1 ZC3HAV1 | 2.49e-09 | 256 | 158 | 12 | 33397691 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 MTA2 UBR4 KSR2 SREBF1 NSD1 KDM3B IRS1 PIP5K1C TIAM2 PIKFYVE STK10 HEG1 SHANK2 EIF4ENIF1 TLN1 BANP NAV2 TLN2 TNFAIP3 CEP170B RASAL1 | 6.73e-09 | 1105 | 158 | 22 | 35748872 |
| Pubmed | 7.88e-09 | 128 | 158 | 9 | 30995482 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CRTC3 ANK3 TCOF1 TRO UBR4 CHD7 PIP5K1C BMI1 STK10 FAM193A EIF4ENIF1 TLN1 CCDC87 CRTC2 | 1.20e-08 | 430 | 158 | 14 | 35044719 |
| Pubmed | MTA2 ANK3 TCOF1 NSD1 KDM3B BEND3 SPAG9 LUZP1 MSH6 LMO7 PHF3 TLN1 CNOT1 ZC3HAV1 RPAP2 | 3.62e-08 | 549 | 158 | 15 | 38280479 | |
| Pubmed | DLG5 CLASP1 KIF26B LUZP1 FAM193A EIF4ENIF1 MACF1 AKAP11 CAMSAP2 CEP170B | 4.57e-08 | 209 | 158 | 10 | 36779422 | |
| Pubmed | MTA2 TCOF1 UBR4 PHRF1 CKAP5 NSD1 BEND3 SPAG9 CHD7 MSH6 PHF3 TLN1 MACF1 PARN CNOT1 ZC3HAV1 | 5.56e-08 | 653 | 158 | 16 | 22586326 | |
| Pubmed | MON2 PRPSAP2 DMXL2 ANK3 RTN4 UBR4 SANBR CKAP5 SNRK OGDH FRMD4A SHANK2 PLPPR4 GPR158 SPHKAP MACF1 TLN2 CAMSAP2 CNOT1 CEP170B RASAL1 | 5.64e-08 | 1139 | 158 | 21 | 36417873 | |
| Pubmed | Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. | 9.20e-08 | 3 | 158 | 3 | 12422220 | |
| Pubmed | RAD51B ANK3 TCOF1 UBR4 ZNF185 IRS1 DCTD OGDH MSH6 NOM1 TLN1 NAV2 MACF1 ZC3HAV1 RPAP2 | 2.31e-07 | 634 | 158 | 15 | 34591612 | |
| Pubmed | ANK3 BEND3 TAB2 PIKFYVE EIF4ENIF1 LMO7 AKAP11 CAMSAP2 CNOT1 CEP170B | 2.51e-07 | 251 | 158 | 10 | 29778605 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DLG5 ANK3 COBLL1 RTN4 ZNF185 CKAP5 TBC1D22B LUZP1 SHANK2 LMO7 TLN1 NAV2 MACF1 ZC3HAV1 | 3.43e-07 | 565 | 158 | 14 | 25468996 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.17e-07 | 203 | 158 | 9 | 22083510 | |
| Pubmed | 4.20e-07 | 101 | 158 | 7 | 10997877 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DMXL2 ANK3 LUZP1 SHANK2 PHF3 MACF1 TLN2 AKAP11 CEP170B RASAL1 | 7.06e-07 | 281 | 158 | 10 | 28706196 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MTA2 GATAD2A RTN4 ZNF185 KDM3B ZNF207 SPAG9 LUZP1 PHF3 TLN1 L3MBTL3 ZC3HAV1 | 9.93e-07 | 444 | 158 | 12 | 34795231 |
| Pubmed | CRTC3 CLASP1 KIAA1549 TBC1D22B LUZP1 FAM193A EIF4ENIF1 LMO7 R3HDM1 CNOT1 CEP170B CRTC2 | 1.04e-06 | 446 | 158 | 12 | 24255178 | |
| Pubmed | DLG5 CLASP1 PHRF1 CKAP5 NSD1 ZNF207 CHD7 LUZP1 MSH6 C18orf21 SHANK2 EIF4ENIF1 PHF3 NOM1 TLN1 MACF1 CDYL PARN SPATS2 CAMSAP2 CEP170B ZC3HAV1 | 1.26e-06 | 1497 | 158 | 22 | 31527615 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CRTC3 CLASP1 TCOF1 KDM3B OSER1 SNRK TAB2 STK10 SHANK2 EIF4ENIF1 WDHD1 SPATS2 R3HDM1 CAMSAP2 CNOT1 CRTC2 ZC3HAV1 RPAP2 | 1.29e-06 | 1038 | 158 | 18 | 26673895 |
| Pubmed | 1.36e-06 | 234 | 158 | 9 | 36243803 | ||
| Pubmed | Genome-wide meta-analysis identifies new susceptibility loci for migraine. | 1.57e-06 | 78 | 158 | 6 | 23793025 | |
| Pubmed | MTA2 DLG5 GATAD2A CLASP1 ZNF280C ZNF207 TBC1D22B ESCO2 STK10 PHF3 MACF1 TLN2 | 1.87e-06 | 472 | 158 | 12 | 38943005 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MTA2 GATAD2A CLASP1 CKAP5 OGDH CDCA2 MSH6 C18orf21 PHF3 NOM1 MACF1 SPATS2 L3MBTL3 CNOT1 ZC3HAV1 | 2.17e-06 | 759 | 158 | 15 | 35915203 |
| Pubmed | MTA2 DMXL2 ANK3 CLASP1 RTN4 ZNF185 CKAP5 KIAA1549 OGDH LUZP1 SHANK2 PLPPR4 LMO7 TLN1 MACF1 TLN2 USP4 CAMSAP2 CNOT1 CEP170B RASAL1 | 2.29e-06 | 1431 | 158 | 21 | 37142655 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CLASP1 TCOF1 PHRF1 CKAP5 KDM3B SPAG9 CHD7 STK10 MSH6 WDHD1 LMO7 PHF3 TLN2 MN1 ZC3HAV1 | 2.76e-06 | 774 | 158 | 15 | 15302935 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 DLG5 CLASP1 TCOF1 TAB2 CHD7 LUZP1 PIKFYVE LMO7 BANP MACF1 CEP170B RPAP2 | 3.20e-06 | 588 | 158 | 13 | 38580884 |
| Pubmed | DMXL2 CENPC KIF26B UBR4 WIPF3 ZNF207 TAB2 MEAK7 STK10 WDHD1 TRPM3 PHF3 USP4 RPAP2 | 3.51e-06 | 689 | 158 | 14 | 36543142 | |
| Pubmed | GATAD2A TCOF1 COBLL1 STK10 MSH6 C18orf21 LMO7 PHF3 NAV2 TLN2 PARN ZC3HAV1 | 3.59e-06 | 503 | 158 | 12 | 16964243 | |
| Pubmed | MTA2 GATAD2A TCOF1 COBLL1 WIPF3 KDM3B LUZP1 MSH6 WDHD1 LMO7 PHF3 TLN1 | 3.82e-06 | 506 | 158 | 12 | 30890647 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAD51B SLC37A1 ANK3 AFF3 KSR2 LAMA3 ATP9B FOXN3 OGDH STK10 SHANK2 PTPRG GPR158 BANP MACF1 WDR45B SPATS2 CNOT1 CEP170B ZC3HAV1 RPAP2 | 4.25e-06 | 1489 | 158 | 21 | 28611215 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MTA2 GATAD2A ZNF280D CENPC ZNF280C NSD1 KDM3B CHD7 CDCA2 BMI1 MSH6 PHF3 CDYL | 4.60e-06 | 608 | 158 | 13 | 36089195 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RTN4 CKAP5 LUZP1 FAM193A EIF4ENIF1 LMO7 PHF3 NOM1 TLN1 MACF1 SPATS2 R3HDM1 CNOT1 ZC3HAV1 | 6.16e-06 | 724 | 158 | 14 | 36232890 |
| Pubmed | 6.28e-06 | 57 | 158 | 5 | 29089450 | ||
| Pubmed | MON2 CLASP1 KDM3B HMGCR CHD7 PIKFYVE FAM193A EIF4ENIF1 FBXO5 WDHD1 PHF3 BANP R3HDM1 RPAP2 | 7.09e-06 | 733 | 158 | 14 | 34672954 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 22976293 | ||
| Pubmed | 8.40e-06 | 104 | 158 | 6 | 10470851 | ||
| Pubmed | 9.89e-06 | 107 | 158 | 6 | 30995489 | ||
| Pubmed | 1.56e-05 | 399 | 158 | 10 | 37536630 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12422219 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15623515 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 35061505 | ||
| Pubmed | CREB coactivators CRTC2 and CRTC3 modulate bone marrow hematopoiesis. | 2.05e-05 | 2 | 158 | 2 | 29078378 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 2.05e-05 | 2 | 158 | 2 | 26523364 | |
| Pubmed | Creb coactivators direct anabolic responses and enhance performance of skeletal muscle. | 2.05e-05 | 2 | 158 | 2 | 24674967 | |
| Pubmed | The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. | 2.05e-05 | 2 | 158 | 2 | 26147081 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 37607946 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22306379 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18342854 | ||
| Pubmed | ZNF280D UBR4 CKAP5 BEND3 CHD7 LUZP1 FAM193A EIF4ENIF1 L3MBTL3 CNOT1 | 2.33e-05 | 418 | 158 | 10 | 34709266 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MTA2 GATAD2A TCOF1 PHRF1 SREBF1 CKAP5 NSD1 BEND3 CHD7 FANCM CDCA2 LMO7 PHF3 NOM1 BANP CDYL L3MBTL3 ZC3HAV1 | 2.60e-05 | 1294 | 158 | 18 | 30804502 |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 3.07e-05 | 265 | 158 | 8 | 19240061 | |
| Pubmed | RAD51B SMG1 CENPC TRO UBR4 SANBR BEND3 OGDH LUZP1 CDCA2 CCDC27 PRDM8 SHANK2 LMO7 SYCP1 NAV2 MACF1 CAMSAP2 CCDC158 | 3.21e-05 | 1442 | 158 | 19 | 35575683 | |
| Pubmed | Tet1 controls meiosis by regulating meiotic gene expression. | 3.23e-05 | 14 | 158 | 3 | 23151479 | |
| Pubmed | Dual role of DMXL2 in olfactory information transmission and the first wave of spermatogenesis. | 3.23e-05 | 14 | 158 | 3 | 30735494 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MON2 MTA2 LCA5 TCTN3 CRTC3 ANK3 CLASP1 COBLL1 ZNF207 SPAG9 LUZP1 EIF4ENIF1 PTPRG LMO7 CAMSAP2 CNOT1 CRTC2 ZC3HAV1 | 3.41e-05 | 1321 | 158 | 18 | 27173435 |
| Pubmed | 3.48e-05 | 197 | 158 | 7 | 36604605 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 4.10e-05 | 358 | 158 | 9 | 32460013 | |
| Pubmed | DLG5 CENPC CKAP5 SPAG9 LUZP1 ESCO2 CDCA2 TLN1 CDYL L3MBTL3 CNOT1 RPAP2 | 4.21e-05 | 645 | 158 | 12 | 25281560 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 4.37e-05 | 361 | 158 | 9 | 26167880 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | SMG1 KDM3B MUC16 CHD7 BMI1 FAM163B FAM193A SHANK2 LMO7 NAV2 AKAP11 | 4.81e-05 | 552 | 158 | 11 | 10737800 |
| Pubmed | MTA2 CRTC3 GATAD2A TCOF1 RBL2 MSH6 C18orf21 FAM193A EIF4ENIF1 NOM1 SPATS2 ZC3HAV1 | 4.88e-05 | 655 | 158 | 12 | 35819319 | |
| Pubmed | 4.97e-05 | 87 | 158 | 5 | 12465718 | ||
| Pubmed | CRTC2 modulates hepatic SREBP1c cleavage by controlling Insig2a expression during fasting. | 6.13e-05 | 3 | 158 | 2 | 29679236 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 38505620 | ||
| Pubmed | TORC2/3-mediated DUSP1 upregulation is essential for human decidualization. | 6.13e-05 | 3 | 158 | 2 | 33780908 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 18792400 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 22665520 | ||
| Pubmed | An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. | 6.13e-05 | 3 | 158 | 2 | 17202407 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 14536081 | ||
| Pubmed | Mechanotransduction in talin through the interaction of the R8 domain with DLC1. | 6.13e-05 | 3 | 158 | 2 | 30028837 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 18638481 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 34686752 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 12782621 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 19952892 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 23572508 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 19160486 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 6.13e-05 | 3 | 158 | 2 | 27816808 | |
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 6.13e-05 | 3 | 158 | 2 | 15494027 | |
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 6.13e-05 | 3 | 158 | 2 | 26634421 | |
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 19056739 | ||
| Pubmed | 6.13e-05 | 3 | 158 | 2 | 28698364 | ||
| Pubmed | CRTC3 RIPOR2 ANK3 KIF26B COBLL1 LAMA3 KIAA1549L NAV2 MACF1 TNFAIP3 | 8.21e-05 | 486 | 158 | 10 | 20936779 | |
| Pubmed | 8.58e-05 | 157 | 158 | 6 | 30186101 | ||
| Pubmed | DLG5 ANK3 TCOF1 COBLL1 RTN4 CKAP5 TAB2 FBXO5 TLN1 MACF1 CNOT1 ZC3HAV1 | 1.02e-04 | 708 | 158 | 12 | 39231216 | |
| Pubmed | 1.20e-04 | 322 | 158 | 8 | 26514267 | ||
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 18188447 | ||
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 23147115 | ||
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 28235073 | ||
| Pubmed | Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. | 1.22e-04 | 4 | 158 | 2 | 16127460 | |
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 26221972 | ||
| Pubmed | Vinculin regulates assembly of talin: β3 integrin complexes. | 1.22e-04 | 4 | 158 | 2 | 24446374 | |
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 14691141 | ||
| Pubmed | 1.22e-04 | 4 | 158 | 2 | 30242097 | ||
| Interaction | YWHAH interactions | LCA5 DLG5 CRTC3 CLASP1 KIF26B COBLL1 KSR2 CKAP5 KDM3B TAB2 TBC1D22B IRS1 LUZP1 CDCA2 FRMD4A LMO7 PHF3 NAV2 MACF1 AKAP11 USP4 TNFAIP3 R3HDM1 CAMSAP2 CEP170B CRTC2 ZC3HAV1 | 8.20e-08 | 1102 | 155 | 27 | int:YWHAH |
| Interaction | YWHAG interactions | LCA5 DLG5 CRTC3 RIPOR2 CLASP1 KIF26B COBLL1 KSR2 CKAP5 KDM3B TAB2 TBC1D22B IRS1 LUZP1 CDCA2 FRMD4A LMO7 PHF3 NAV2 MACF1 AKAP11 TNFAIP3 R3HDM1 CAMSAP2 CEP170B CRTC2 ZC3HAV1 | 9.59e-07 | 1248 | 155 | 27 | int:YWHAG |
| Interaction | H3C1 interactions | RAD51B MTA2 GATAD2A ZNF280D ANK3 CENPC COBLL1 UBR4 ZNF280C NSD1 SPAG9 CHD7 ESCO2 CDCA2 PIKFYVE BMI1 MSH6 PHF3 NAV2 CDYL PARN L3MBTL3 | 1.59e-06 | 901 | 155 | 22 | int:H3C1 |
| Interaction | MAPRE3 interactions | DLG5 CENPC CLASP1 CKAP5 LUZP1 LMO7 NAV2 MACF1 CAMSAP2 CEP170B RPAP2 | 1.72e-06 | 230 | 155 | 11 | int:MAPRE3 |
| Interaction | RCOR1 interactions | MTA2 GATAD2A UBR4 CKAP5 BEND3 SPAG9 CHD7 DCAF12L2 LUZP1 ESCO2 MSH6 FAM193A EIF4ENIF1 WDHD1 L3MBTL3 | 6.59e-06 | 494 | 155 | 15 | int:RCOR1 |
| Interaction | MTNR1B interactions | 9.91e-06 | 135 | 155 | 8 | int:MTNR1B | |
| Interaction | PHLPP1 interactions | DLG5 TCOF1 SYNM KIF26B RTN4 CKAP5 LUZP1 CDCA2 EIF4ENIF1 LMO7 TLN1 ZC3HAV1 | 1.07e-05 | 333 | 155 | 12 | int:PHLPP1 |
| Interaction | YWHAE interactions | MTA2 PRPSAP2 LCA5 DLG5 CRTC3 CLASP1 KIF26B COBLL1 KSR2 CKAP5 TAB2 TBC1D22B IRS1 LUZP1 BMI1 FRMD4A LMO7 NAV2 MACF1 AKAP11 TNFAIP3 R3HDM1 CAMSAP2 CEP170B CRTC2 | 1.10e-05 | 1256 | 155 | 25 | int:YWHAE |
| Interaction | YWHAQ interactions | LCA5 DLG5 CRTC3 ZNF280D CLASP1 KIF26B COBLL1 KSR2 TAB2 IRS1 SPAG9 LUZP1 WDHD1 LMO7 TLN1 NAV2 MACF1 AKAP11 TNFAIP3 R3HDM1 CAMSAP2 CEP170B CRTC2 | 1.53e-05 | 1118 | 155 | 23 | int:YWHAQ |
| Interaction | FMR1 interactions | SMG1 CLASP1 TCOF1 UBR4 CKAP5 CHD7 LUZP1 EIF4ENIF1 PLPPR4 MACF1 R3HDM1 CAMSAP2 CNOT1 CEP170B ZC3HAV1 | 1.73e-05 | 536 | 155 | 15 | int:FMR1 |
| Interaction | SFN interactions | CRTC3 CLASP1 KIF26B COBLL1 TAB2 IRS1 LUZP1 BMI1 LMO7 PHF3 BANP NAV2 MACF1 AKAP11 USP4 CAMSAP2 CEP170B | 2.49e-05 | 692 | 155 | 17 | int:SFN |
| Interaction | YWHAZ interactions | LCA5 DLG5 DMXL2 CRTC3 RIPOR2 CLASP1 KIF26B TEDC2 COBLL1 KSR2 CKAP5 TAB2 TBC1D22B IRS1 LUZP1 LMO7 PHF3 NAV2 MACF1 AKAP11 TNFAIP3 R3HDM1 CAMSAP2 CEP170B CRTC2 | 2.51e-05 | 1319 | 155 | 25 | int:YWHAZ |
| Interaction | CDH1 interactions | DLG5 ANK3 COBLL1 RTN4 ZNF185 CKAP5 TBC1D22B IRS1 PIP5K1C LUZP1 SHANK2 PTPRG CLEC4A LMO7 TLN1 NAV2 MACF1 ZC3HAV1 | 2.64e-05 | 768 | 155 | 18 | int:CDH1 |
| Interaction | RNF43 interactions | DLG5 ANK3 SYNM CKAP5 KIAA1549 TAB2 TBC1D22B FAM193A EIF4ENIF1 MACF1 R3HDM1 CNOT1 ZC3HAV1 | 2.71e-05 | 427 | 155 | 13 | int:RNF43 |
| Interaction | YWHAB interactions | LCA5 DLG5 CRTC3 CLASP1 KIF26B COBLL1 KSR2 TBC1D22B IRS1 LUZP1 LMO7 PHF3 NAV2 MACF1 AKAP11 USP4 TNFAIP3 R3HDM1 CAMSAP2 CEP170B CRTC2 | 3.39e-05 | 1014 | 155 | 21 | int:YWHAB |
| Interaction | AGAP2 interactions | 3.69e-05 | 210 | 155 | 9 | int:AGAP2 | |
| Interaction | KRT8 interactions | SMG1 DLG5 CLASP1 SYNM UBR4 BMI1 FAM193A EIF4ENIF1 AKAP11 USP4 CAMSAP2 CNOT1 RPAP2 | 3.78e-05 | 441 | 155 | 13 | int:KRT8 |
| Interaction | ZC3H7A interactions | 4.43e-05 | 215 | 155 | 9 | int:ZC3H7A | |
| Interaction | FXR1 interactions | SMG1 TCOF1 TBC1D22B DCTD LUZP1 ESCO2 BMI1 KIAA1549L EIF4ENIF1 SPHKAP CDYL SPATS2 R3HDM1 CNOT1 CEP170B ZC3HAV1 | 7.13e-05 | 679 | 155 | 16 | int:FXR1 |
| Interaction | OTUD7A interactions | 8.32e-05 | 58 | 155 | 5 | int:OTUD7A | |
| Interaction | BRCA1 interactions | RAD51B MTA2 SDK2 ZNF280D TCOF1 RBL2 UBR4 CKAP5 ZNF207 SPAG9 FANCM DCTD OGDH LUZP1 CDCA2 MSH6 FBXO5 WDHD1 TLN1 ETAA1 CNOT1 ZC3HAV1 RPAP2 | 8.52e-05 | 1249 | 155 | 23 | int:BRCA1 |
| Interaction | POLR1G interactions | MTA2 GATAD2A CENPC TCOF1 UBR4 NSD1 BEND3 CHD7 CDCA2 WDHD1 PHF3 PARN RPAP2 | 1.08e-04 | 489 | 155 | 13 | int:POLR1G |
| Interaction | H3C3 interactions | MTA2 GATAD2A ZNF280D CENPC ZNF280C NSD1 KDM3B CHD7 CDCA2 BMI1 MSH6 PHF3 CDYL | 1.21e-04 | 495 | 155 | 13 | int:H3C3 |
| Interaction | TOP3B interactions | MON2 MTA2 UBR4 KSR2 SREBF1 NSD1 KDM3B IRS1 PIP5K1C TIAM2 PIKFYVE STK10 HEG1 SHANK2 EIF4ENIF1 LRRC31 TLN1 BANP NAV2 TLN2 TNFAIP3 CNOT1 CEP170B RASAL1 ZC3HAV1 | 1.44e-04 | 1470 | 155 | 25 | int:TOP3B |
| Interaction | H2BC8 interactions | RAD51B GATAD2A ZNF280D CENPC ZNF280C NSD1 CHD7 ESCO2 CDCA2 MSH6 PHF3 AKAP11 CDYL L3MBTL3 | 1.49e-04 | 576 | 155 | 14 | int:H2BC8 |
| Interaction | KDM3A interactions | 1.66e-04 | 67 | 155 | 5 | int:KDM3A | |
| Interaction | DCAF4 interactions | SLC37A1 CENPC TCOF1 TRO ZNF280C BEND3 FAM193A EIF4ENIF1 SPATS2 R3HDM1 CNOT1 | 1.70e-04 | 378 | 155 | 11 | int:DCAF4 |
| Interaction | SIRT7 interactions | MTA2 TCOF1 UBR4 PHRF1 CKAP5 NSD1 BEND3 SPAG9 CHD7 MSH6 PHF3 TLN1 MACF1 PARN CNOT1 ZC3HAV1 | 2.04e-04 | 744 | 155 | 16 | int:SIRT7 |
| Cytoband | 6q25.2 | 1.42e-05 | 14 | 158 | 3 | 6q25.2 | |
| Cytoband | 2q36 | 3.25e-04 | 8 | 158 | 2 | 2q36 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.84e-04 | 29 | 89 | 3 | 396 | |
| GeneFamily | BEN domain containing | 8.43e-04 | 9 | 89 | 2 | 422 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.91e-03 | 50 | 89 | 3 | 1293 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.41e-03 | 15 | 89 | 2 | 82 | |
| GeneFamily | Immunoglobulin like domain containing | 2.65e-03 | 193 | 89 | 5 | 594 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 CENPC CLASP1 CKAP5 KDM3B TAB2 IRS1 SPAG9 FOXN3 PIKFYVE STK10 MSH6 HEG1 FAM193A WDHD1 PHF3 MACF1 AKAP11 CDYL PARN R3HDM1 CAMSAP2 MN1 | 1.58e-09 | 856 | 156 | 23 | M4500 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MON2 RAD51B DLG5 SDK2 CLASP1 RBL2 TAB2 ATP9B IRS1 HMGCR CHD7 DCTD STC1 CDCA2 MSH6 ETAA1 NAV2 WDR45B CDYL PARN TNFAIP3 SPATS2 MN1 | 3.39e-08 | 1009 | 156 | 23 | M157 |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D8 | 8.06e-08 | 37 | 156 | 6 | M15693 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MON2 CRTC3 RBL2 NSD1 KDM3B ZNF207 CCDC80 SNRK TAB2 IRS1 DCTD SLC18B1 TIAM2 SHANK2 PTPRG PDGFD TNFAIP3 | 6.83e-06 | 807 | 156 | 17 | M16651 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SLC37A1 RIPOR2 ANK3 RTN4 AFF3 KSR2 LAMA3 KIAA1549 FOXN3 SOCS7 PRDM8 SHANK2 KIAA1549L PLPPR4 GPR158 KCNK2 TLN2 RAB11FIP4 R3HDM1 CAMSAP2 | 9.77e-06 | 1106 | 156 | 20 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CLASP1 CKAP5 TAB2 IRS1 FOXN3 PIKFYVE HEG1 PHF3 CDYL PARN R3HDM1 CAMSAP2 | 2.42e-05 | 466 | 156 | 12 | M13522 |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN | 2.48e-05 | 197 | 156 | 8 | M3438 | |
| Coexpression | GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN | 2.66e-05 | 199 | 156 | 8 | M8148 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | 2.66e-05 | 199 | 156 | 8 | M3846 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 2.68e-05 | 145 | 156 | 7 | M1810 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | RAD51B DLG5 DMXL2 SDK2 ANK3 SYNM MYCT1 MEAK7 FRMD4A MSH6 PRDM8 HEG1 LRRC31 PHF3 TLN2 CCL25 ZC3HAV1 | 3.13e-05 | 909 | 156 | 17 | M41018 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 3.65e-05 | 208 | 156 | 8 | M39233 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | SLC37A1 NSD1 DCAF12L2 PRDM8 C18orf21 PLPPR4 TRPM3 KCNK2 MN1 CEP170B RASAL1 ZC3HAV1 | 4.18e-05 | 493 | 156 | 12 | M1951 |
| Coexpression | FISCHER_DREAM_TARGETS | RAD51B GATAD2A CENPC TCOF1 TEDC2 CKAP5 ZNF207 SPAG9 FANCM ESCO2 CDCA2 MSH6 FBXO5 WDHD1 SPATS2 R3HDM1 CNOT1 | 6.90e-05 | 969 | 156 | 17 | M149 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 8.21e-05 | 300 | 156 | 9 | M8702 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.06e-04 | 180 | 156 | 7 | M8239 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 | EFCAB6 SANBR KIAA1549 DNAJC27 ATP9B DUSP19 TYRO3 SHANK2 CCDC87 SPATS2 AGBL2 | 1.26e-04 | 471 | 156 | 11 | M3062 |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 1.68e-04 | 194 | 156 | 7 | M4943 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CACNA1D DMXL2 CENPC SYNM COBLL1 RTN4 SREBF1 TAB2 CHD7 FOXN3 SOCS7 PIKFYVE GPR158 NAV2 AKAP11 ST18 | 1.73e-04 | 946 | 156 | 16 | M39169 |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 1.79e-04 | 196 | 156 | 7 | M9243 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.84e-04 | 197 | 156 | 7 | M8983 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP | 1.84e-04 | 197 | 156 | 7 | M4485 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 1.90e-04 | 198 | 156 | 7 | M7605 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 1.96e-04 | 199 | 156 | 7 | M9964 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_UP | 1.96e-04 | 199 | 156 | 7 | M7784 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP | 2.02e-04 | 200 | 156 | 7 | M5994 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP | 2.02e-04 | 200 | 156 | 7 | M5066 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_708_5P_GENES | 2.08e-04 | 49 | 156 | 4 | MM17508 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 RIPOR2 CD244 CENPC RBL2 UBR4 NSD1 SNRK TAB2 LUZP1 PIKFYVE STK10 HEG1 PHF3 TLN1 MACF1 AKAP11 TNFAIP3 LY9 CNOT1 ZC3HAV1 | 2.15e-04 | 1492 | 156 | 21 | M40023 |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 2.19e-04 | 20 | 156 | 3 | M1189 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | SLC37A1 NSD1 PRDM8 C18orf21 PLPPR4 TRPM3 KCNK2 MN1 CEP170B RASAL1 ZC3HAV1 | 2.27e-04 | 504 | 156 | 11 | MM830 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZNF280D CENPC CLASP1 TCOF1 SANBR CKAP5 NSD1 KIAA1549 BEND3 HMGCR FANCM DCTD LUZP1 ESCO2 CDCA2 FRMD4A MSH6 HEG1 C18orf21 FAM193A SHANK2 KIAA1549L FBXO5 PHF3 ETAA1 MACF1 R3HDM1 | 2.68e-07 | 1257 | 152 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZNF280D CENPC CLASP1 TCOF1 SANBR CKAP5 NSD1 KIAA1549 BEND3 HMGCR CHD7 FANCM DCTD LUZP1 ESCO2 CDCA2 FRMD4A MSH6 HEG1 C18orf21 FAM193A SHANK2 KIAA1549L FBXO5 PHF3 ETAA1 MACF1 R3HDM1 | 1.48e-06 | 1459 | 152 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | ANK3 CLASP1 NSD1 ZNF207 FAM193A PTPRG PHF3 TLN2 MYOCD CDYL CAMSAP2 L3MBTL3 | 1.46e-05 | 369 | 152 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | LCA5 RIPOR2 ZNF280D CENPC CLASP1 KSR2 SANBR CKAP5 KIAA1549 HMGCR CHD7 FOXN3 FANCM DCTD CDCA2 FRMD4A HEG1 KIAA1549L MACF1 RAB11FIP4 R3HDM1 | 2.25e-05 | 1060 | 152 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CENPC RTN4 SANBR CKAP5 ZNF207 CHD7 FANCM LUZP1 CDCA2 MSH6 PHF3 ETAA1 CHST2 CNOT1 | 2.98e-05 | 532 | 152 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | MON2 LCA5 SYNM KIF26B MYCT1 TRPC3 WIPF3 SANBR KIAA1549 IGSF5 CHD7 CDCA2 CLEC4A PDGFD KCNK2 MYOCD CHST2 | 1.06e-04 | 836 | 152 | 17 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.14e-04 | 261 | 152 | 9 | gudmap_developingKidney_e11.5_ureteric bud_1000_k1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1D SDK2 KSR2 IRS1 FAM163B TRPM3 GPR158 SPHKAP AKAP11 ST18 | 8.78e-10 | 178 | 158 | 10 | fcbbcc44271515de1969b4732b6441c012693d5f |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D ANK3 AFF3 KSR2 FRMD4A SHANK2 KIAA1549L PLPPR4 GPR158 R3HDM1 | 2.46e-09 | 198 | 158 | 10 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1D SDK2 KIAA1549 IRS1 FAM163B TRPM3 GPR158 SPHKAP AKAP11 | 1.29e-08 | 174 | 158 | 9 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-08 | 189 | 158 | 9 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D AFF3 KSR2 FRMD4A SHANK2 KIAA1549L PLPPR4 GPR158 R3HDM1 | 3.60e-08 | 196 | 158 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-08 | 197 | 158 | 9 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D AFF3 KSR2 FRMD4A SHANK2 KIAA1549L PLPPR4 GPR158 R3HDM1 | 3.93e-08 | 198 | 158 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D AFF3 KSR2 FRMD4A SHANK2 KIAA1549L PLPPR4 GPR158 R3HDM1 | 3.93e-08 | 198 | 158 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CACNA1D ANK3 AFF3 KSR2 FRMD4A SHANK2 KIAA1549L PLPPR4 R3HDM1 | 4.29e-08 | 200 | 158 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.93e-07 | 189 | 158 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-07 | 191 | 158 | 8 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.43e-07 | 192 | 158 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.61e-07 | 193 | 158 | 8 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 4.61e-07 | 193 | 158 | 8 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.79e-07 | 194 | 158 | 8 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.79e-07 | 194 | 158 | 8 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.79e-07 | 194 | 158 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.98e-07 | 195 | 158 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.03e-07 | 200 | 158 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.79e-06 | 161 | 158 | 7 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.37e-06 | 168 | 158 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-06 | 177 | 158 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-06 | 179 | 158 | 7 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-06 | 180 | 158 | 7 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-06 | 180 | 158 | 7 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.74e-06 | 180 | 158 | 7 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 4.02e-06 | 182 | 158 | 7 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-06 | 185 | 158 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 185 | 158 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 187 | 158 | 7 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 187 | 158 | 7 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.98e-06 | 188 | 158 | 7 | 0a47de24812c619f6756c9351a413b109128d54f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-06 | 188 | 158 | 7 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.98e-06 | 188 | 158 | 7 | c0a03e33027f52b5c25ffbc8f822128e5160ed20 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.16e-06 | 189 | 158 | 7 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 5.34e-06 | 190 | 158 | 7 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-06 | 190 | 158 | 7 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-06 | 190 | 158 | 7 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.53e-06 | 191 | 158 | 7 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-06 | 192 | 158 | 7 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.72e-06 | 192 | 158 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-06 | 192 | 158 | 7 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.92e-06 | 193 | 158 | 7 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.92e-06 | 193 | 158 | 7 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.92e-06 | 193 | 158 | 7 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.92e-06 | 193 | 158 | 7 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.12e-06 | 194 | 158 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-06 | 194 | 158 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-06 | 194 | 158 | 7 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 6.33e-06 | 195 | 158 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 6.33e-06 | 195 | 158 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 195 | 158 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.55e-06 | 196 | 158 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.55e-06 | 196 | 158 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.55e-06 | 196 | 158 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.55e-06 | 196 | 158 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.55e-06 | 196 | 158 | 7 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | MS-cycling-|MS / Condition, Cell_class and T cell subcluster | 6.99e-06 | 198 | 158 | 7 | 19c5d6b65de490118574b1f86b45c58b3a51df7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.99e-06 | 198 | 158 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.99e-06 | 198 | 158 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.99e-06 | 198 | 158 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.99e-06 | 198 | 158 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | MS-cycling|MS / Condition, Cell_class and T cell subcluster | 6.99e-06 | 198 | 158 | 7 | 0c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.23e-06 | 199 | 158 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.23e-06 | 199 | 158 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.23e-06 | 199 | 158 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.47e-06 | 200 | 158 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.47e-06 | 200 | 158 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 7.47e-06 | 200 | 158 | 7 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.01e-05 | 156 | 158 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 162 | 158 | 6 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 162 | 158 | 6 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 162 | 158 | 6 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.57e-05 | 163 | 158 | 6 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.57e-05 | 163 | 158 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.57e-05 | 163 | 158 | 6 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-05 | 164 | 158 | 6 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 164 | 158 | 6 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.94e-05 | 167 | 158 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 169 | 158 | 6 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.25e-05 | 170 | 158 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.36e-05 | 171 | 158 | 6 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 171 | 158 | 6 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.83e-05 | 175 | 158 | 6 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 176 | 158 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 176 | 158 | 6 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.08e-05 | 177 | 158 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-05 | 179 | 158 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-05 | 180 | 158 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.48e-05 | 180 | 158 | 6 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 4.48e-05 | 180 | 158 | 6 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 4.62e-05 | 181 | 158 | 6 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 182 | 158 | 6 | 5f1f10c845b73d1f69794277925ef847ff23ac2d | |
| ToppCell | 3'_v3-blood-Hematopoietic_Erythro-Mega-Mega-Mast|blood / Manually curated celltypes from each tissue | 4.76e-05 | 182 | 158 | 6 | 1923b5669901f828e890416c22d1f1d21a4a2c6a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 158 | 6 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.91e-05 | 183 | 158 | 6 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-05 | 183 | 158 | 6 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 184 | 158 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Disease | neuroimaging measurement | RAD51B GATAD2A ANK3 KIF26B AFF3 KSR2 BEND3 CHD7 MEAK7 LUZP1 PDGFD SYCP1 KCNK2 NAV2 MACF1 TLN2 L3MBTL3 CRTC2 | 1.52e-05 | 1069 | 156 | 18 | EFO_0004346 |
| Disease | migraine with aura | 2.78e-05 | 2 | 156 | 2 | MONDO_0005475 | |
| Disease | lymphocyte count | RAD51B TCTN3 RIPOR2 MYCT1 COBLL1 RTN4 SANBR SREBF1 NSD1 OSER1 BEND3 CHD7 MEAK7 TLN1 USP4 CHST2 LY9 AGBL2 L3MBTL3 ZC3HAV1 RPAP2 | 3.14e-05 | 1464 | 156 | 21 | EFO_0004587 |
| Disease | intellectual disability (implicated_via_orthology) | 4.96e-05 | 75 | 156 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Headache, fasting blood insulin measurement | 1.65e-04 | 4 | 156 | 2 | EFO_0004466, HP_0002315 | |
| Disease | waist-hip ratio | RAD51B DMXL2 ZNF280D ANK3 RBL2 COBLL1 AFF3 NSD1 DNAJC27 DCAF12L2 CHRM2 STC1 CDCA2 PTPRG ETAA1 L3MBTL3 MN1 | 2.79e-04 | 1226 | 156 | 17 | EFO_0004343 |
| Disease | alcohol consumption measurement | CACNA1D DLG5 ZNF280D COBLL1 RTN4 AFF3 CHRM2 CHRNA3 ESCO2 TYRO3 FRMD4A SPHKAP AKAP11 RAB11FIP4 SPATS2 AGBL2 ST18 | 3.23e-04 | 1242 | 156 | 17 | EFO_0007878 |
| Disease | Drug habituation | 3.72e-04 | 115 | 156 | 5 | C0013170 | |
| Disease | Drug abuse | 3.72e-04 | 115 | 156 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.72e-04 | 115 | 156 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 3.72e-04 | 115 | 156 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 3.72e-04 | 115 | 156 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.72e-04 | 115 | 156 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.72e-04 | 115 | 156 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.72e-04 | 115 | 156 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.72e-04 | 115 | 156 | 5 | C0029231 | |
| Disease | Substance abuse problem | 3.87e-04 | 116 | 156 | 5 | C0740858 | |
| Disease | urinary albumin to creatinine ratio | 3.93e-04 | 179 | 156 | 6 | EFO_0007778 | |
| Disease | myeloid white cell count | RAD51B DLG5 MYCT1 WIPF3 SREBF1 CHD7 LCT MEAK7 TLN2 AKAP11 TNFAIP3 L3MBTL3 ZC3HAV1 RPAP2 | 4.73e-04 | 937 | 156 | 14 | EFO_0007988 |
| Disease | Manic Disorder | 5.55e-04 | 71 | 156 | 4 | C0024713 | |
| Disease | lactase-phlorizin hydrolase measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0801753 | |
| Disease | Manic | 7.91e-04 | 78 | 156 | 4 | C0338831 | |
| Disease | Depression, Bipolar | 8.30e-04 | 79 | 156 | 4 | C0005587 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.03e-03 | 144 | 156 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | thalamus volume | 1.09e-03 | 85 | 156 | 4 | EFO_0006935 | |
| Disease | reticulocyte measurement | RAD51B GATAD2A CLASP1 MYCT1 COBLL1 AFF3 BEND3 DNAJC27 IRS1 PIKFYVE TLN2 USP4 L3MBTL3 ZC3HAV1 | 1.45e-03 | 1053 | 156 | 14 | EFO_0010700 |
| Disease | neutrophil percentage of leukocytes | 1.57e-03 | 610 | 156 | 10 | EFO_0007990 | |
| Disease | platelet crit | RAD51B GATAD2A AFF3 OSER1 TBC1D22B HMGCR MEAK7 GMCL2 TLN1 BANP CHST2 MN1 ZC3HAV1 | 1.70e-03 | 952 | 156 | 13 | EFO_0007985 |
| Disease | forced expiratory volume, traffic air pollution measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0004314, EFO_0007908 | |
| Disease | xanthine measurement | 2.08e-03 | 13 | 156 | 2 | EFO_0010548 | |
| Disease | cortical surface area measurement | MON2 RAD51B ANK3 KIF26B SREBF1 BEND3 HMGCR CHD7 LUZP1 PDGFD KCNK2 NAV2 MACF1 TLN2 RAB11FIP4 L3MBTL3 | 2.10e-03 | 1345 | 156 | 16 | EFO_0010736 |
| Disease | Hepatic fibrosis | 2.23e-03 | 49 | 156 | 3 | HP_0001395 | |
| Disease | endometriosis | 2.29e-03 | 252 | 156 | 6 | EFO_0001065 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.38e-03 | 105 | 156 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 2.38e-03 | 105 | 156 | 4 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | cortical thickness | MON2 RAD51B RIPOR2 GATAD2A SREBF1 BEND3 CHD7 LUZP1 KCNK2 NAV2 MACF1 RAB11FIP4 AGBL2 ST18 | 2.42e-03 | 1113 | 156 | 14 | EFO_0004840 |
| Disease | trimethylamine-N-oxide measurement | 2.42e-03 | 14 | 156 | 2 | EFO_0010541 | |
| Disease | susceptibility to bacterial meningitis measurement | 2.65e-03 | 52 | 156 | 3 | EFO_0008411 | |
| Disease | Intellectual Disability | 2.69e-03 | 447 | 156 | 8 | C3714756 | |
| Disease | monoclonal gammopathy | 2.80e-03 | 53 | 156 | 3 | EFO_0000203 | |
| Disease | migraine disorder | 2.99e-03 | 357 | 156 | 7 | MONDO_0005277 | |
| Disease | smoking status measurement | MON2 CACNA1D GATAD2A AFF3 ZNF207 DNAJC27 SNRK CHD7 FOXN3 FAM163B PTPRG KCNK2 NAV2 AGBL2 | 3.50e-03 | 1160 | 156 | 14 | EFO_0006527 |
| Disease | SLAM family member 7 measurement | 3.59e-03 | 17 | 156 | 2 | EFO_0008287 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 3.59e-03 | 17 | 156 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | respiratory symptom change measurement, response to placebo | 3.59e-03 | 17 | 156 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | mean reticulocyte volume | RAD51B RIPOR2 GATAD2A CLASP1 TRO TRPC3 AFF3 OSER1 BEND3 TLN2 MN1 | 3.59e-03 | 799 | 156 | 11 | EFO_0010701 |
| Disease | reticulocyte count | GATAD2A CLASP1 MYCT1 COBLL1 ZNF280C LAMA3 BEND3 IRS1 PIKFYVE TLN2 USP4 L3MBTL3 ZC3HAV1 | 3.77e-03 | 1045 | 156 | 13 | EFO_0007986 |
| Disease | free androgen index | 3.86e-03 | 374 | 156 | 7 | EFO_0007005 | |
| Disease | syndrome (implicated_via_orthology) | 4.02e-03 | 18 | 156 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | visceral adipose tissue measurement | 4.19e-03 | 481 | 156 | 8 | EFO_0004765 | |
| Disease | non-lobar intracerebral hemorrhage | 4.56e-03 | 63 | 156 | 3 | EFO_0010178 | |
| Disease | body fat percentage | 4.56e-03 | 488 | 156 | 8 | EFO_0007800 | |
| Disease | end stage renal disease (implicated_via_orthology) | 4.96e-03 | 20 | 156 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 4.98e-03 | 65 | 156 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | soluble triggering receptor expressed on myeloid cells 2 measurement | 5.02e-03 | 296 | 156 | 6 | EFO_0010151 | |
| Disease | verbal-numerical reasoning measurement | 5.24e-03 | 131 | 156 | 4 | EFO_0008394 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AASASKQAARPVLAT | 541 | P23470 | |
| SSFLSKRPSTSEVNN | 171 | Q6N043 | |
| QSLAVKSFSRRTPNS | 326 | Q8N9N5 | |
| RPNGNSLFTSASSSK | 901 | P51826 | |
| SSKFSNPISSSKRNV | 126 | O15444 | |
| SLAFTAAATQKTSSP | 141 | Q6UXZ3 | |
| KSTLNTAGFSSSQAP | 701 | Q9NQI0 | |
| KISNFSANLTRSSSS | 411 | P32297 | |
| TSFNIQVSPSLTSFK | 1761 | Q8IZF6 | |
| ATAASFSAAAASPQK | 46 | Q53H80 | |
| FFRQGSLASSKPASN | 1606 | Q9UKA4 | |
| NSSNNSLALTSPYKT | 6 | P08172 | |
| GSSKQPLRNAATRTF | 701 | Q8TDJ6 | |
| SRSSASSQKGPQALT | 1096 | Q9Y4F5 | |
| SNPNRFFKKTNLSSS | 746 | Q9NVE4 | |
| SNFSSLSSKFILPNV | 2456 | Q9P2D1 | |
| SPFALAVVKRSQSFS | 986 | Q53SF7 | |
| VQSSNSQFRVSSKRP | 626 | P78312 | |
| SSSPNILASFAGKNR | 136 | Q76M96 | |
| KPGLSSFRSTFRQQS | 21 | Q2M243 | |
| LATFPSISAAQNALK | 1056 | Q15032 | |
| KAQRSADFSPAFLST | 71 | O15315 | |
| DPNTLFRSNSLASKS | 336 | O95294 | |
| AQSLSPYTTSANRAK | 431 | O94776 | |
| LSPKFNLSSSISSEN | 751 | Q96L73 | |
| ANSPNRKISSTAFGR | 296 | Q86YS3 | |
| NSFTAPSTVGKRNLS | 556 | O95453 | |
| FSRLFSSSSNTTKKP | 556 | O60271 | |
| PIFSSSQQRKQVSDS | 26 | Q9UPP5 | |
| LDSSFSVIANKNTPS | 566 | Q9HCM3 | |
| FPRNKRTDANESSSS | 611 | Q96JM7 | |
| RSFNDSAFAKPSSLL | 1261 | Q6ZRR7 | |
| SSNRPRKTSSLSLFF | 826 | Q08999 | |
| FEKANASNSPSSLRL | 156 | Q5T5X7 | |
| TSAESPASRQAAAKL | 336 | Q86YP4 | |
| PLFSAASTSAAKQRN | 2091 | Q8WXI7 | |
| AAKTSTTNRALTNSP | 10801 | Q8WXI7 | |
| PQTASRFCKNSARSL | 1241 | Q16787 | |
| ASPSSAIRTNFSTKQ | 226 | Q9GZZ0 | |
| KRPTTNSSASFTKEQ | 191 | Q9NZQ0 | |
| RSVALPASSALSANK | 1186 | Q5T848 | |
| RASTLAKFALSSNSQ | 136 | P04035 | |
| NVSKTSELNQFSLSP | 911 | A6NM62 | |
| NNTGSTPLRKAQSSA | 516 | O43861 | |
| SVKSSSLPRAFQKAS | 1531 | Q2KJY2 | |
| AKNAVSAATFSLPSA | 1211 | Q5HYC2 | |
| RSPTKFINSFGNASS | 1961 | Q5HYC2 | |
| RDSLSKTSTPFNKSN | 4376 | Q2LD37 | |
| SARSFPRKASQTSIF | 641 | Q6VAB6 | |
| NSVPSGSSAQSKVRS | 1706 | Q8IYD8 | |
| SAAQNSKPRLSFSTK | 26 | O95069 | |
| SSFANRPRKSSVNGS | 306 | P35226 | |
| ASTNPSNRKVRALAF | 256 | Q5VW00 | |
| TSATPQSASIKALRN | 21 | Q9GZP0 | |
| PQTSTVNKFLRGSNA | 16 | Q6UY01 | |
| PSSARLGSSSNLQFK | 1256 | Q8TDM6 | |
| LSAKRAAPVSFQRNS | 531 | Q9P1Y6 | |
| SSASNSNSELKAIRP | 1196 | Q7LBC6 | |
| NSSSPASTGAKTNRA | 3416 | O94854 | |
| SPFSSLSQDQAATSK | 991 | Q8WWI1 | |
| NFSDSSKSRTPRKSA | 821 | P09848 | |
| AKTSERSNPFSQKSS | 561 | Q86VQ0 | |
| SRKLASATANDSANP | 136 | Q6ZVL6 | |
| LAPKSATFAVQSSTQ | 961 | Q9ULI3 | |
| NSPNVSSKSFSLKAL | 36 | Q6P9B6 | |
| NIKFRQGSSTSSSPA | 286 | Q7Z3U7 | |
| LPSAQQRTKAFSTCS | 226 | Q8NGE2 | |
| SDEFRPRSKSQSSSN | 261 | P35568 | |
| SETKNTLRAFSAPQN | 331 | P52701 | |
| PSAQQRKKAFSTCSS | 226 | A6NM76 | |
| FASQVPVKRQSSSSE | 581 | Q8IZQ8 | |
| AKARASSVNAAPTSF | 911 | Q9NY74 | |
| RNTVKNSSTASLAPS | 101 | Q86UQ5 | |
| ASQTVKTFSQNRPAA | 16 | Q02218 | |
| DNLANSASPSKRTSV | 486 | Q9Y2I7 | |
| KATSAALPQSQRSST | 981 | Q9P2Q2 | |
| VRFSSQNRKSGSAAP | 61 | P57057 | |
| FISNVKTALAATNPA | 756 | Q14008 | |
| ASFNLASPEKVSNTT | 391 | Q9NSI5 | |
| RFAKTLLANSSPFNV | 156 | P27352 | |
| SNIKISAFSFPNTSL | 81 | Q8NFQ6 | |
| QISRSTNSNFSKTSP | 136 | Q9Y232 | |
| NGSPNKFRSSSTTAV | 36 | Q5THR3 | |
| KFRSSSTTAVANPTL | 41 | Q5THR3 | |
| SLANDFSTNSTKSVP | 46 | Q03188 | |
| FRTPLASVQKSAAQT | 321 | Q9UKT4 | |
| AVAFLSAQRSKDPNS | 21 | P32321 | |
| ASTSFSQKSPQARAL | 76 | P0C2L3 | |
| SATASASNPRKFSEK | 11 | Q53ET0 | |
| SSRSNPSIQATLNKT | 326 | Q6UUV7 | |
| NYSSAKSSNARSTSP | 336 | O00409 | |
| SLAKATTAPATTRNT | 121 | P01880 | |
| FTVSCSPKRTINSSQ | 851 | Q5U5Z8 | |
| DSNSFTKSAAALLSP | 1841 | Q12955 | |
| VSSPSFTNRRAAKAS | 421 | Q86V48 | |
| ANQGSPFKSALSTVS | 71 | Q56NI9 | |
| RPSKDSSSFRQAQCL | 71 | Q7Z601 | |
| FSSKPQRSQLQIFSS | 16 | Q9HBG7 | |
| LQVSFAVLSSPNKSS | 461 | Q69YH5 | |
| VAKSPASAKRAQSFA | 186 | O60256 | |
| FTSAASPSVKNSASR | 996 | Q5M9N0 | |
| SPSVKNSASRSFNSS | 1001 | Q5M9N0 | |
| NSASRSFNSSPKKSP | 1006 | Q5M9N0 | |
| TNSTSTQQGSLFRPK | 2116 | Q58EX2 | |
| SGSRKRNHSPSFNST | 326 | Q9BZW8 | |
| TQTKRSTFDNFPQAL | 681 | Q01668 | |
| PQSSNRKSASFSVKS | 971 | Q08AD1 | |
| KSRSFVSTLKSNPAT | 116 | Q32NC0 | |
| FQPSQRTSASKLGAL | 791 | Q10571 | |
| SSSDNPQALVKASRS | 1061 | Q10571 | |
| STKTSNPFLVAAQDS | 511 | Q9NQC3 | |
| LSQPVSRASSVSKQS | 1106 | Q2M3C7 | |
| SSPSFQTLNSKVALA | 81 | Q9NU19 | |
| GKAVSSQTNVRTFSP | 416 | O15061 | |
| SKGTSSLSQQTPRFN | 161 | Q9NYJ8 | |
| AQAQAASTPRKARAS | 976 | Q13428 | |
| RLPAAFRKAASQNSS | 206 | Q7L2K0 | |
| SSSILAKAFPNNVAT | 151 | Q6NT16 | |
| EQANSFPRKSSFRAS | 151 | Q8N699 | |
| NTVFRKNSSLKSSPS | 441 | O60331 | |
| ERKSAFSQPARSFSQ | 496 | Q9NQV8 | |
| FKRNTLNQPRSGSVS | 431 | Q8NEA9 | |
| PSFAAAVRSNTGQKT | 3536 | Q96Q15 | |
| SSYANTPASSRKNLD | 976 | Q8IVL1 | |
| ATAKTRPSAAATAAA | 156 | Q5C9Z4 | |
| ARSPTTELSSKSQQA | 381 | A6NGB9 | |
| DPKRNKQSSLASASF | 261 | Q5MNZ6 | |
| ASVPVSARQSSSEKN | 691 | Q6NSI8 | |
| SSDATQVPQASLKAS | 166 | Q9NX31 | |
| QTRSASPSNIKAQFR | 346 | Q9NRH2 | |
| QAFATSPASKAARES | 161 | Q9Y4F9 | |
| QNSAAKVSPATRSDT | 926 | Q9UPX8 | |
| SSSPFKTSSILVNAA | 641 | O60284 | |
| SVSPRKSRVAAQNSA | 26 | P52823 | |
| NRLAAGSKAPASAQS | 306 | P36956 | |
| NSKLSALQRSSCSTP | 756 | Q9NRA8 | |
| SKPFVVSARNATQAA | 466 | Q9Y4C5 | |
| INTASSAASKERTAP | 21 | Q9UMR7 | |
| SSSSQESLNRPLSAK | 556 | Q7Z460 | |
| STNLKNSFASALRTA | 1466 | A5YKK6 | |
| QASFKTATPRAISTS | 51 | Q53QW1 | |
| QENISTSPKSSSARA | 541 | Q7Z2D5 | |
| AKSLSRPTTETQFSN | 206 | Q86XZ4 | |
| RQTLQSKSSTAPSRN | 226 | Q13107 | |
| AKKPFNQSSSLSSLR | 286 | Q8IVF5 | |
| APSASQRRKRTSFSA | 81 | Q9H2W2 | |
| SGKVSPTASRFQNTI | 641 | P21580 | |
| AATKARATESQTPNA | 346 | Q12816 | |
| NTQSSSNSTLPERLK | 296 | Q8IXW5 | |
| DSKAVPSQTVSRNFT | 811 | Q15431 | |
| LASARTTNPTAKRQF | 1511 | Q9Y490 | |
| TASLRNPFQRSKSSK | 1691 | Q9HCF6 | |
| SSQGRVNPFKVSASS | 906 | O75717 | |
| DLSPAANRSQKASQS | 436 | O94804 | |
| ANRSQKASQSRPNSS | 441 | O94804 | |
| AASASKPSADQIRQS | 916 | Q92576 | |
| KLTRTQSAFSPVSFS | 266 | O14512 | |
| SSKALFPSTAQAQAA | 281 | O43670 | |
| TPDKLAQAAQSSAAT | 2041 | Q9Y4G6 | |
| NTTARNPRKSNASRS | 546 | Q8ND82 | |
| QPAKTSSVSLTATFR | 701 | Q7Z2W4 | |
| AFQQSTAASLTSPRS | 366 | Q6NUS6 | |
| KSSRTSVQPTFTASQ | 3841 | Q5T4S7 | |
| ATSVSAVPADRKSNS | 376 | O15231 | |
| AAPFNITVTKLSSSN | 226 | Q06418 | |
| GNSKSRLNLFTQSNS | 731 | Q13507 | |
| LFSTSEPNLTKSQSN | 496 | A8MPX8 | |
| TSFTSAFSLVKNARP | 171 | Q8WTR2 |